at their C terminus retain their function and correct subcellular localization. However, a minority of proteins may require an intact C terminus for correct localization and biological function 17, 18 . Although we have demonstrated that the C-terminal TAP tag did not interfere with the biological function of any of the myogenic factors and chromatin modifiers we have studied thus far 11, 14 , we recommend that an appropriate functional validation assay be carried out for any new TAP-tagged fusion construct as a first step in the ChTAP-seq pipeline. The validation steps include western blot analysis for the expression of the TAP-tagged construct using an antibody against FLAG epitope, DNA binding of the tagged protein with electrophoretic shift assay and correct subcellular localization, as described previously 11, 12 .
Generation of stable cell lines expressing TAP-tagged protein.
To generate a stable cell line expressing the TAP-tagged construct of interest, retroviral vectors harboring the gene of interest fused with a C-terminal TAP-tag (His 6 -TEV-FLAG 3 ) 11, 14 are created. In our studies, retroviral particles were generated by transfection of Phoenix helper-free retrovirus producer cell line (a kind gift from G. Nolan, http://www.stanford.edu/group/nolan/retroviral_ systems/phx.html), also available from ATCC, as described previously 11, 14 . Other vectors such as lentiviral and adenoviral systems can be equally useful in the production of stable cell lines expressing the TAP-tagged protein. In addition, tetracycline-inducible vectors or other alternatives can be used in ChTAP pipeline for the temporally controlled expression of the protein of interest.
Chromatin tandem affinity purification. The next stage of the protocol involves the implementation of ChTAP, which is a derivative of TAP purification that was first applied to the identification of yeast protein complexes 13, 15 and later to the study
Box 1 | Direct comparison of ChTAP and ChIP
To undertake a direct comparison of ChTAP with TAP tag purification and ChIP with endogenous antibody, we first identified genome-wide target sites of key myogenic factors such as Pax3, Pax7, Myf5 and MyoD and others using ChTAP-seq 11, 12 . We selected the MyoD data set for direct comparison because of the commercial availability of a ChIP-grade MyoD antibody. Furthermore, genome-wide MyoD binding sites using an endogenous MyoD antibody have been previously reported 21, 22 .
We selected 20 random sites from the MyoD ChTAP-seq data set in primary myotubes 12 and performed ChIP-qPCR analysis of these target sites using an antibody against the endogenous MyoD. This analysis revealed that ChTAP is a robust method for identification of bona fide MyoD binding sites 12 . Furthermore, in a direct comparison between ChTAP-qPCR (i.e., TAP purification of chromatin) and ChIP-qPCR with the endogenous MyoD antibody, our data show that ChTAP-qPCR is as efficient as ChIP-qPCR with a ChIP-grade antibody 12 . Finally, a direct correlation analysis for tag enrichment on ~5,800 common sites between our MyoD ChTAP-seq in primary myotubes and an independent MyoD ChIP-seq in C2C12 myotubes 21 showed a significant positive correlation (see the figure in this box). Together, these results indicate that ChTAP can be applied for robust identification of a bona fide binding site of any DNA-binding protein without the requirement for a ChIP-grade antibody. Figure 1 | Chromatin tandem affinity purification. The protein of interest is expressed as a C-terminal, TAP-tagged fusion protein at near-physiological levels. Cells stably expressing the fusion protein are subjected to a process by which proteins attached to chromatin are cross-linked to DNA by formaldehyde (using a 1% (vol/vol) formaldehyde solution in 1× PBS). After cell lysis and chromatin shearing, the DNA-bound protein complex of interest is purified using anti-FLAG 3 antibody conjugated to agarose beads. After three sequential washes, the complex is eluted from the beads by either FLAG 3 peptide competition or proteolytic cleavage with TEV protease. The eluted material is used for a second step of purification using nickel affinity gel. Further contaminants are removed by three washes, and chromatin is eluted from the beads with imidazole. The protein-DNA complex is dissociated by reverse cross-linking, and DNA is purified by phenol/chloroform extraction. of diverse organisms 14, 19, 20 . TAP was designed for two primary reasons: first, to eliminate the requirement for a specific antibody for immunoprecipitation and second, to purify protein complexes to near-homogeneity through sequential immunoprecipitations with two independent epitopes. Both of these qualities also apply to ChTAP.
Assessment of background noise.
As for most other highthroughput, genome-wide approaches, the 'signal' obtained after implementation of ChIP-seq tends to be characterized by a high background noise level. The background noise could result from structural differences in chromatin mappability or systematic biases of immunoprecipitation for certain genomic landmarks 21, 22 . The most widely used controls for peak calling are input DNA (purified, sheared genomic DNA) or a generic pseudo-random sequence with the same read distribution created by a Poisson or negative binomial algorithm 7, [23] [24] [25] [26] . Another control that has been used is a mock IP (mock ChIP). Mock ChIP goes through the same process of selection as the experimental ChIP, but in the absence of the antibody. Other controls for these experiments could include performing ChIP on cells or tissues in which the gene encoding the protein being studied has been knocked out, or performing ChIP in the presence of a blocking peptide that binds to the antibody on which the ChIP experiment is based, thus preventing further antibody binding to the target protein.
The approach we have taken follows the recommendations of existing best practices as set forth by the Encyclopedia of DNA Elements (ENCODE) and Model Organism ENCODE (modENCODE) consortia 27 . To perform the experimental and control ChIP under identical conditions, we used empty vector ChIP, a control that is similar to a mock ChIP. However, unlike the mock ChIP, in our control empty vector ChIP we use the same antibody and beads as the experimental ChIP. In this control, the TAP tag is not fused with the protein of interest; therefore, any enrichment arising from it is probably attributable to nonspecific binding to beads, tags or other factors during the ChIP process.
To provide a quantitative estimate of the extent of background noise in ChIP-seq data and to assess the read distribution, we analyzed the distribution of reads in 500-bp windows across the genome for ChTAP-seq, empty vector control and the input DNA data. The 500-bp window approximately matches the average peak length in our data sets. Notably, our analysis shows that a Poisson model is a poor fit for the read distributions in all of these data sets ( Fig. 2 and Supplementary Fig. 1 ).
We believe that using a cell type-specific matching affinity control is crucial for objective assessment of background noise in ChIP-seq data. We provide a methodology and a detailed protocol to map genome-wide binding sites of any DNA-binding protein without requirement for a ChIP-grade antibody. Our method of background subtraction can be broadly applied to the analysis of any ChIP-seq data set. The genome was divided into 500-bp windows and, for each data set, the number of reads per window was calculated. These counts were used to derive the frequency of windows with read numbers ranging from 0 to 29. Windows with reads ≥30 were also counted. Data were normalized to 10 million reads to adjust for differences in read counts among data sets. 
Generating stable cell lines expressing a TAP-tagged construct
To generate stable cell lines expressing a TAP-tagged construct, first obtain a C-terminal TAP-tagged fusion construct by removing the stop codon from the ORF of the gene of interests and fuse the ORF with the His 6 -TEV-FLAG 3 tag as described previously 14 . Next, validate the construct by sequencing, by western blot analysis after transfection of the plasmid into a mammalian cell line such as HEK293T cells, as well as by electrophoretic shift assay as described previously 11, 12 . Subsequently, generate retroviral particles by transfecting the plasmid into helper-free Pheonix-ECO or HEK293T cells as described previously 14 . Generate stable cells overexpressing low levels of TAP-tagged protein by infecting cells of interest with low ( <10) MOI, as described previously 11, 12, 14 . A parallel cell line overexpressing the TAP tag not fused to any protein in the same cell line, as the experimental ChIP, is required as a cell type-specific affinity control. This cell line should be generated concurrently with the cell line harboring the TAP-tagged protein of interest.
• • • proceDure cell harvesting, lysis and chromatin shearing • tIMInG ~3 h ! cautIon All work involving retroviruses should be performed in a class II biosafety chamber. Personal protective equipment such as gloves and a lab coat should be worn at all times. Any waste containing retrovirus vectors should be disposed of according to approved biosafety guidelines.  crItIcal This protocol describes the purification of chromatin using two independent epitopes. Starting material is 100-150 million cells.
1|
Aspirate the medium from growing adherent cells and rinse them with 1× PBS solution. Please note that Steps 1-6 of the PROCEDURE apply to adherent cells. The procedure can, however, easily be adapted to nonadherent cells with minimum effort and no extra reagents or equipment.  crItIcal step To minimize cell loss from inadvertently dislodging cells from the plate, add the PBS solution gently.
2|
Add the ChIP fixation buffer. The amount of fixation buffer depends on the plate size. Add up to 15 ml per 15-cm plate or enough to cover the entire surface of the plate, and then place the plates on a horizontal shaker at room temperature (22 °C) for 10 min with gentle rotation.
3|
Gently pour off the fixation buffer into a labeled container for waste disposal. Add quenching (glycine) buffer and place the plates on a horizontal shaker for 5 min at room temperature with gentle rotation.
4| Wash the cells with 1× ice-cold PBS solution containing protease inhibitors (leupeptin 100 µM; pepstatin A 100 µM; aprotinin 10 µg ml − 1 ; PMSF 1 mM). Aspirate the wash buffer and replenish the plates with an additional 5 ml of ice-cold 1× PBS.
5|
Collect the cells using a cell scraper, and then add the cell-PBS mixture into a 50-ml Falcon tube. Combine all cell material per experiment in one tube.
6|
Collect the cell pellet using a refrigerated centrifuge by spinning the tube at 700g for 5 min at 4 °C.
7|
Carefully pour off the PBS without losing the cell pellet.
8| Add to the cell pellets ChIP lysis buffer containing working concentration of protease inhibitors as described in
Step 4, and then place the tube on ice for 15-20 min. Follow a 2:1 (vol/wt) ratio for the amount of lysis buffer to cell pellet.
9|
Dispense the cell lysate in 0.5-ml aliquots into 1.5-ml Eppendorf tubes.
10| Place the tubes from
Step 8 into a water bath sonicator or Bioruptor with circulating cold water. Sonication time will need to be empirically determined for each cell or tissue type. Typically, to get chromatin shearing within the range of 100-300 bp for ChIP-seq, we sonicate for 30 cycles (30 s on and 60 s off) using a Diagenode Bioruptor on the high power setting. ? trouBlesHootInG 11| Assess the quality of DNA shearing by implementing the procedure detailed in Box 2. Also prepare a sample of input DNA control as described in Box 3. Once the shearing of chromatin has achieved optimal fragmentation size, typically between 100 and 300 bp as assessed by agarose gel and ethidium bromide visualization, take 2% of the input and proceed to the preparation of input DNA for sequencing (Box 3). While implementing that procedure, incubate the sample from
Step 10 at − 20 °C.
chromatin tandem affinity purification • tIMInG ~3-4 d 12| Transfer the cell lysate from Step 10 and centrifuge it at 20,000g for 10 min in a refrigerated microcentrifuge at 4 °C. Transfer the supernatant to a freshly labeled 15-ml Eppendorf tube. Be careful to avoid carrying over the insoluble material and pellet.
13|
Add an equal volume of ChIP dilution buffer to the supernatant from Step 12. At this stage, one should typically have 5-6 ml of diluted lysate.
14|
Place 150 µl of the anti-FLAG affinity gel in a 1.5-ml Eppendorf tube and add 1,350 µl of M2 wash buffer.
15|
Place the samples on a fixed rotation mixer in a refrigerated room at 4 °C for 5 min with constant rotation to wash beads.
16|
Collect beads by centrifugation at 400g for 1-2 min in a refrigerated centrifuge at 4 °C. Carefully aspirate the supernatants and dissolve the beads in M2 wash buffer again as described in Step 15.
17| Repeat
Step 16 two more times.
18|
After the final wash, mix the anti-FLAG M2 affinity gel (beads) in 150 µl of M2 wash buffer and directly add it to the cell lysate from Step 13; and incubate the lysate on a fixed rotation mixer at 4 °C for 3 h.
19|
Pellet the beads by centrifugation at 400g at 4 °C for 1-2 min. Carefully transfer the supernatant to an Eppendorf tube and label it as flow-through no. 1.
20| (Optional)
We advise using the supernatant from Step 19 for western blot analysis to determine the efficiency of binding (capturing antigen), a procedure that will help troubleshoot the experiment in case of experimental failure.
21| Wash beads from
Step 19 with up to 10 volumes of M2 wash buffer; transfer the slurry to a freshly labeled low-retention (siliconized) 1.5-ml Eppendorf tube.
22| Repeat
Step 21 two more times.
Box 2 | Assessing the shearing efficiency of chromatin during sonication
• tIMInG ~1 d 30| Incubate the samples on a fixed rotation mixer with rotation at 4 °C for 2-3 h.
31|
Centrifuge the tubes at 400g for 1-2 min at 4 °C and carefully pour off the supernatant.
32|
Wash the beads containing chromatin with 1,350 µl of nickel wash buffer as described in Steps 25-27.
33|
Centrifuge the tubes at 400g in a refrigerated centrifuge at 4 °C and pour off the supernatant.
34|
Add 250 µl of elution buffer (250-400 mM imidazole in H 2 O). Incubate the samples on a fixed rotation mixer at room temperature for at least 1 h with continuous rotation. Please note that longer incubation times with elution buffer usually increase the elution efficiency.
35| Set up poly-prep chromatography columns. Attach a 25G 5/8 needle to the bottom of the column.
36| Pour 5 ml of nickel wash buffer directly into the columns and let the column drain completely under gravity.
37|
After the column has completely drained, place a labeled 1.5-ml low-retention (siliconized) Eppendorf tube at the bottom of the column beneath the needle to collect the eluate from the next step.
? trouBlesHootInG 38| Pour the slurry from
Step 34 directly onto the column and let it drain into the collection tube under gravity. Please note that, occasionally, clogging occurs and the flow stops. When this happens, apply a slight pressure to the top of the column with the palm of your gloved hand, which will restart the flow. The sample is generally drained in 2-5 min. Step 24B, chromatin elution by photolytic cleavage using TEV protease: 1 d Steps 25-39, final purification of chromatin by Ni-NTA affinity chromatography (His 6 tag purification): 0.5 d Steps 40-43, reverse cross-linking of chromatin and ChIP DNA purification: 1 d
Step 44, ChTAP library construction and sequencing: ~2-3 d
antIcIpateD results
The yield of ChIP DNA is typically in the range of 5-50 ng, and it varies depending of the protein under investigation. The yield of control ChIP is substantially less than the yield of the experimental ChIP. If the quantity of ChIP DNA is substantially lower than expected, the chromatin may have been lost during recovery throughout the pipeline. Western blot analysis of samples from Steps 20, 24B(vi) and 39 should be performed to find out the step(s) that require troubleshooting. When there are known binding sites for the protein of interest, we recommend that a quick quality control test be performed by quantitative real-time PCR using locus-specific primers before proceeding with ChIP library construction and sequencing in order to ascertain whether the ChIP DNA is enriched for the bona fide binding sites.
